PTSD

ClinicalJuly 31, 2026

Mobile App-Delivered ACT Shows Efficacy in PTSD Treatment in China

A secondary analysis of a randomized controlled trial indicates that mobile app-delivered Acceptance and Commitment Therapy significantly improves PTSD symptoms through mediating components of psychological flexibility.

ClinicalJuly 31, 2026

PPMT shows feasibility and acceptability in PTSD treatment, insights for protocol refinement

A pilot trial of the Processing of Positive Memories Technique (PPMT) indicated strong feasibility and acceptability among clients and therapists for treating PTSD.

ClinicalJuly 30, 2026

Pilot Study on Psychotherapy for PTSD in HIV Patients

A pilot study is exploring a non-exposure based psychotherapy for PTSD in people living with HIV.

ClinicalJuly 30, 2026

Study on rTMS for PTSD in Veterans Aims to Understand Mechanisms of Action

The study investigates the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on PTSD symptoms in veterans, focusing on brain function and inflammation.

ClinicalJuly 23, 2026

Post-ICU PTSD Intervention Shows Potential for Improving Quality of Life

A secondary analysis of the PICTURE trial indicates that a brief primary care intervention may improve health-related quality of life in ICU survivors with PTSD symptoms.

ClinicalJuly 18, 2026

Study on Non-invasive Vagus Nerve Stimulation for PTSD Underway

A study is being conducted to evaluate the effects of non-invasive vagus nerve stimulation on fear learning in PTSD patients.

ClinicalJuly 14, 2026

Intranasal Insulin Shows Potential for Treating PTSD Symptoms

A clinical trial is underway to assess the efficacy of intranasal insulin in reducing symptoms of PTSD.

ClinicalJuly 9, 2026

Adapting STAIR-NT for Polysubstance Users in Opioid Treatment Programs

The STAIR-NT intervention was adapted for patients using stimulants and opioids, showing promise in meeting treatment needs.

ClinicalJuly 1, 2026

Phase 2 Trial of Daridorexant for PTSD Under Adaptive Platform Design

A Phase 2 trial is underway to evaluate daridorexant's safety and efficacy in PTSD patients.

ClinicalJune 30, 2026

Non-Inferiority Trial of TrIGR for PTSD Shows Promise Against Standard Therapy

A non-inferiority trial is underway to compare Trauma Informed Guilt Reduction Therapy (TrIGR) with cognitive processing therapy (CPT) for PTSD treatment in Veterans.

ClinicalJune 21, 2026

Study on Predictors of PTSD Relapse in Children and Families

This study aims to identify clinical and neuropsychological markers that may predict PTSD relapse in children and their families.

ClinicalJune 10, 2026

Study Compares PE Therapy, Pharmacotherapy, and Combination for PTSD in Veterans

A randomized trial will compare the effectiveness of Prolonged Exposure therapy, paroxetine, venlafaxine, and their combination in veterans with PTSD.

Companies

Assets

Recent signals(12)